CLINICAL_TRIALS trial_result · 2022-05-19

Clinical Trial Update: Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography [Phase 2]

View source ↗

Summary

Phase 2 trial exploring the impact of PCSK9 inhibitors on coronary microvascular dysfunction in patients with atherosclerotic cardiovascular disease confirmed b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Atherosclerotic Cardiovascular Disease | Phase 2 | Status: UNKNOWN